Specifically, a recent study demonstrated the recruitment of myeloid cells to the tumor in a mouse mammary tumor model following treatment with doxorubicin [38] and GDF15 can enhance the tumor-initiating and self-renewal potential of multiple myeloma cells [39]. This evidence concerns the gene GDF15 and plasma cell myeloma.